The Alpha-1 Association of Australia (AAA) was established to support families and those affected by or interested in Alpha-1 Antitrypsin Deficiency (AATD). AATD is a genetically inherited medical condition which can seriously affect the liver, lungs and skin.
AATD can manifest as emphysema in adults as young as 30 years, sometimes younger and is a significant cause of liver transplants in children.
AATD is under-recognised, taking an average of ~8 years between initial patient presentation and diagnosis. Yet it’s estimated that around 1 in 9 Australians carry a defective Alpha-1 Antitrypsin (AAT) gene. AATD is often misdiagnosed as asthma or bronchitis.
The AAA is an unfunded not for profit organisation partnering with professionals and other organisations to help raise awareness of and raise funding for a range of projects including:
* An Australian AATD national research registry;
* Inclusion of AATD in newborn screening for early diagnosis;
* Access to AATD augmentation therapy;
* General awareness raising events;
* Providing education and patient support.
All donations will help achieve our objectives.